Navigation Links
CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health
Date:7/29/2008

hp [CoSign's digital signature solution] at all of the SCDMH locations will eliminate the printing and signing of close to 10,000 documents each day. In the four healthcare facilities currently using CoSign, the migration to a paperless workflow has reduced the processing time by days. Paper-related expenses have been reduced by thousands of dollars. In conjunction with the implementation of CoSign, the organization has also employed numerous "point of service" signing pad locations. These locations allow patients to http://www.arx.com/documents/digital_signatures_in_a_document_intensive_organization.php [electronically sign documents], which healthcare employees can then verify with their own digital signatures, further alleviating SCDMH from having to reintroduce paper documents into the workflow for signing purposes.

"SCDMH's implementation of CoSign emphasizes the marketplace's increasing recognition of the benefits that the CoSign digital signature solution offers, including accelerated workflow processes and reduced workloads," said Rodd Schlerf, Sales Manager at ARX. Rodd added, "SCDMH's deployment also conveys the flexibility of the CoSign's digital signature solution by highlighting its capacity to easily incorporate third-party elements using a signing pad."

About the South Carolina Department of Mental Health
The S.C. Department of Mental Health gives priority to adults, children, and their families affected by serious mental illnesses and significant emotional disorders. They are committed to eliminating stigma and promoting the philosophy of recovery, to achieving its goals in collaboration with all stakeholders, and to assuring the highest quality of culturally competent services possible. For more information please visit

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Digital Healthcare Wins FDA Approval for Retasure
2. Digital Healthcare Wins FDA Approval for Retasure
3. Astra Tech Acquires Innovative Dental Digital Technology Company
4. Digital Info Security Company and DGF MedServ, Inc. Announce Intent to Partner in Marketing DGIF IT Solutions to Medical Industry
5. Publicis Groupe Strengthens its Leadership in Digital and Integrated Healthcare Communications in Italy
6. Digital Healthcare Announces Dr. Michael Fleming Joins Executive Team as Medical Director
7. Siemens Rolls Out Its First Mobile Digital Mammography System in the U.S.
8. SMRT Architects and Engineers Selected to Design New $115M Digital X-Ray Manufacturing Facility for GE Healthcare
9. Digital Healthcare Announces Appointment of Dr. Suber Huang as Medical Director
10. Keeneland Scales Eklin Digital Repository(TM) to 32 Medical Image Review Workstations
11. Radlink Introduces New Family of Digital Imaging Products
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health
CoSign Digital Signature Healthcare Solution for South Carolina Department of Mental Health
(Date:12/4/2009)...Late recurrence is a risk for some pediatric cance...central nervous system, according to a new study p...National Cancer Institute . , This study was und...recurrence (after 5 years and up to 20 years) for ...sker, M.D., of the Aflac Cancer Center and Blood D...
(Date:12/4/2009)...Case Western Reserve University researchers, from ...discovered two new metabolic pathways by which pro...e, known as 4-hydroxyacids, are metabolized. The p...lomics and mass isotopomer analysis. The findings ...rug of abuse gamma-hydroxybutyrate, also known as ...
(Date:12/4/2009)... Dental tourism is a phenom...for an alternative to the high price of dental wor... search for lower priced dental care, people have ...ce as a dental tourist destination. , ...ng in business for more than 6 years, Mexican Dent...
(Date:12/4/2009)...ve a response to pressure from federal regulators ... , FRIDAY, Dec. 4 (HealthDay News) -- The ma...riday presented federal regulators with plans to c...rmaceutical companies have been under pressure fro...ind a way to stop the hundreds of fatal overdoses ...
(Date:12/4/2009)...search and surveillance urged for at-risk patient ...s) -- Some childhood cancers, particularly Ewing s...he risk of late recurrence, U.S. researchers have ...2,795 five-year survivors of the most common pedia...ncer Survivor Study. , The researchers found th...
Breaking Medicine News(10 mins):Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Makers of Powerful Painkillers Present Safety Plans 2
...e of Fayette,County,s largest employers will expan...of an $8.4 million, 20-year investment by the comm...,000 grant each year through the,Fayette County Re...uction of a new,inpatient tower that will hold 56 ...
...ants for Families and Honors for Corporate Suppor...ies Affected, GURNEE, Ill., Nov. 5 This year you...oney for pediatric cancer research and,families of...uper hero costumes at this year,s Super Jake Found...
...Heart,Association and its Pharmaceutical Roundtabl...he Outcomes Research Centers initiative. The proje...troke research focusing on,the end results, or out...eart Association national board member David Spina...
...agni, President,and CEO of America,s Health Insura...ment congratulating President-elect Barack Obama:,...r his historic victory,last night. Now is the time... care challenges facing the nation. We,support cov...
...he American,Nurses Association (ANA) congratulates...tory, and looks forward to working with the new ad...change for nurses and the patients we,serve., Pre...wn a commitment to advancing the nursing professio...
...ward to health system reform in 2009, WASHINGTON,...lsen, M.D., AMA President:, "The American Medical...Obama on his successful bid for the presidency of ... President-elect Obama,s focus on expanding health...
Other Medicine News:Health News:State to Invest $8.4 Million in Uniontown Hospital's Expansion 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 2Health News:Super Jake Foundation Hosts 4th Annual 'Heroes Bash' on Nov. 8 to Benefit Pediatric Cancer Research 3Health News:Four Medical Centers Awarded Funds to Improve Outcomes Research for Heart Disease and Stroke 2Health News:AMA Congratulates President-Elect Obama 2
(Date:12/4/2009)... , MORRISTOWN, N.J., Dec. 4 /PRNewswire-Fir...PI ), a leading global specialty pharmaceutical co... Laboratories, Inc.-Florida, filed an Abbreviated ... Drug Administration seeking approval to market it... a patent owned by Takeda Pharmaceutical Company L...
(Date:12/4/2009)... , BETHESDA, Md., Dec. 4 Drs....s for prostate-specific antigen (PSA) recurrence f...s of biochemical recurrence rate in a Phase III pi...or injection) or monthly leuprolide in prostate ca... Prostate cancer patients who received FIRMAGON 24...
(Date:12/4/2009)... , WILMINGTON, Del., Dec. 4 /PRNewswire-Firs...ed that the US Food and Drug Administration (FDA) ...ine fumarate) Extended Release Tablets as adjuncti... with Major Depressive Disorder (MDD). SEROQUEL XR...he FDA to treat both major depressive disorder as ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Novel K anonymity algorithm safeguards access to data 61811 1Flax and yellow flowers can produce bioethanol 10835 1Flax and yellow flowers can produce bioethanol 10835 2Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 1Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 2Parents 3A Holiday Safety Tips from Massachusetts Child Injury Lawyer Thomas M Kiley 61808 3
...06, Demonstrated No Reproductive Toxicity in ... Selected as Clinical Candidate, Demonstrated a 40...ce Daily Oral Dosing -, SAN DIEGO, May 22 Ardea ... preclinical data on its lead non-nucleoside,rever...806, demonstrating,no reproductive toxicity. In ad...
...ull Data Set from the TRIUMPH-1 Trial of Inhaled ...SPRING, Md., May 21 United,Therapeutics Corporati...y,Lung Rx, Inc. today announced that data from sev...nary arterial hypertension (PAH) with treprostinil...TS) meeting in Toronto,Ontario. The ATS presentati...
Other Medicine Technology:Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 2Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 3Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 2Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 3Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 4Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 5Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration 6
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
...loped over Guidants 20-year history, the VOYAGER R...for successful treatment outcomes. It combines a n...ofile shaft,more flexible markers, and short taper...tortuous anatomy with even greater confidence, ope...
AFP EIA Kit
Medicine Products: